Announcement on Receiving the Decision of Stock Termination of Listing
Securities Code: 002411
Securities Abbreviation: *ST Bicon
Announcement Number: 2023-095
Yan'an Bicon Pharmaceutical Co., Ltd. and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or major omissions.
Special Reminder:
- Type of securities to be terminated: RMB ordinary shares; Securities abbreviation: *ST Bicon; Securities code: 002411.
- The trading start date for the delisting transition period is June 19, 2023, lasting fifteen trading days, with the expected last trading date on July 11, 2023.
- During the delisting transition period, the stock will trade on the risk warning board. On the first trading day of the transition period, there will be no price limit, and thereafter, a daily price limit of 10% will apply.
- Investors, securities companies, and other market participants are advised to settle stock pledge repurchase, agreed repurchase, margin financing, transfer, and Shenzhen Stock Connect transactions before the stock is delisted.
- For judicial freeze transactions expiring after the stock is delisted and before the completion of the initial registration in the delisting section, it is recommended that the competent authorities handle the renewal of the freeze procedures in advance through the original enforcement channels before the stock is delisted.
Yan'an Bicon Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") received the Shenzhen Stock Exchange's decision on June 9, 2023, regarding the termination of the listing of the Company's stock (Shenzhen Stock Exchange [2023] No. 487). The Shenzhen Stock Exchange has decided to terminate the listing of the Company's stock.
1. Type of Securities to be Terminated, Securities Abbreviation, Securities Code
Type of securities: RMB ordinary shares
Securities abbreviation: *ST Bicon
Securities code: 002411